# RAPIDIRON Trial Follow-up Study: RAPIDIRON-KIDS Study

> **NCT05504863** · — · UNKNOWN · sponsor: **Thomas Jefferson University** · enrollment: 538 (actual)

## Conditions studied

- Iron Deficiency Anemia
- Neurodevelopmental Abnormality
- Autism Spectrum Disorder

## Interventions

- **DRUG:** Ferric carboxymaltose
- **DRUG:** Iron isomaltoside
- **DRUG:** Ferric Sulfate

## Key facts

- **NCT ID:** NCT05504863
- **Lead sponsor:** Thomas Jefferson University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-10-11
- **Primary completion:** 2025-01
- **Final completion:** 2026-01
- **Target enrollment:** 538 (ACTUAL)
- **Last updated:** 2023-11-29

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05504863

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05504863, "RAPIDIRON Trial Follow-up Study: RAPIDIRON-KIDS Study". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT05504863. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*